Physician
Asuncion, Monina
Asuncion, Monina was paid $618K by Medicaid between Mar 2018 and Nov 2024, across 112 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 25% of everything it billed.
33Billing provider infoASUNCION, MONINA
PASADENA, TX 77504
PASADENA, TX 77504
33aNPI1386600559assigned 04/25/2006
33bProvider typePediatrics Physician
28Total paid$618K
24GClaims80,258
24DCodes billed112
24AFirst – last monthMar 2018 – Nov 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#460 of 1,136
Median peer was paid$329K
This provider vs. median1.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 875 | $14K | |
| 2019 | 50,338 | $228K | |
| 2020 | 789 | $6K | |
| 2021 | 5,435 | $39K | |
| 2022 | 9,259 | $106K | |
| 2023 | 9,783 | $154K | |
| 2024incomplete | 3,779 | $70K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 4,956 | 3,748 | $156K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 9.4% | 1,811 | 1,406 | $58K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 9.0% | 4,933 | 2,445 | $56K |
| 94010 | 6.3% | 3,303 | 2,541 | $39K | |
| 96112 | 5.3% | 1,048 | 839 | $33K | |
| 95012 | 4.4% | 3,342 | 2,544 | $27K | |
| 92081 | 4.3% | 3,045 | 2,505 | $27K | |
| 99078 | 3.7% | 2,865 | 2,069 | $23K | |
| 92552 | 3.3% | 2,814 | 2,293 | $20K | |
| 99000 | 2.9% | 6,403 | 2,225 | $18K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.4% | 2,331 | 1,026 | $15K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.0% | 394 | 314 | $13K |
100 more codes
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.9% | 539 | $12K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.8% | 446 | $11K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.4% | 1,750 | $9K |
| 99213 | Doctor's office visit, returning patient (routine) | 1.4% | 272 | $9K |
| 83655 | 1.3% | 959 | $8K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.2% | 1,887 | $7K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.1% | 1,924 | $7K |
| 95076 | 1.0% | 314 | $6K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 889 | $6K |
| 99441 | <1% | 266 | $6K | |
| 36406 | <1% | 1,253 | $5K | |
| 69210 | <1% | 677 | $5K | |
| 80061 | Lipid panel | <1% | 1,024 | $5K |
| 98960 | <1% | 8,701 | $4K | |
| 36410 | <1% | 2,134 | $4K | |
| 99354 | <1% | 1,079 | $4K | |
| 99205 | Prolong outpt/office vis | <1% | 102 | $4K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,975 | $3K |
| 90671 | <1% | 13 | $3K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 640 | $2K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 461 | $2K |
| 90461 | <1% | 1,039 | $2K | |
| 96111 | <1% | 14 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 29 | $1K |
| 87420 | <1% | 1,062 | $880.82 | |
| 15852 | <1% | 444 | $718.34 | |
| 94760 | <1% | 3,051 | $714.44 | |
| 87430 | <1% | 310 | $708.10 | |
| 99050 | <1% | 242 | $628.10 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 128 | $417.14 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 295 | $385.15 |
| 99381 | <1% | 16 | $364.40 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 30 | $346.74 |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 14 | $291.30 |
| 80053 | Comprehensive metabolic panel | <1% | 166 | $238.55 |
| 99355 | <1% | 164 | $215.44 | |
| 99051 | <1% | 45 | $179.34 | |
| 81000 | <1% | 802 | $178.52 | |
| 93000 | <1% | 12 | $161.64 | |
| 86580 | <1% | 33 | $109.50 | |
| 94761 | <1% | 114 | $76.65 | |
| 90734 | <1% | 32 | $75.00 | |
| 90651 | <1% | 53 | $75.00 | |
| 83013 | <1% | 19 | $69.85 | |
| 85014 | <1% | 66 | $63.80 | |
| 80502 | <1% | 60 | $58.94 | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 56 | $32.35 |
| 85018 | <1% | 22 | $24.10 | |
| 90688 | <1% | 100 | $17.56 | |
| 81003 | <1% | 60 | $16.31 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 567 | $13.47 |
| 96160 | <1% | 470 | $9.28 | |
| 82465 | <1% | 12 | $8.75 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 491 | $0.93 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 795 | $0.58 |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | <1% | 55 | $0.24 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 64 | $0.20 |
| 84439 | 0% | 71 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 118 | $0.00 |
| 82570 | 0% | 60 | $0.00 | |
| 3725F | 0% | 15 | $0.00 | |
| 90633 | 0% | 46 | $0.00 | |
| 99358 | Prolong nursin fac eval 15m | 0% | 93 | $0.00 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 27 | $0.00 |
| 86703 | 0% | 373 | $0.00 | |
| 99173 | 0% | 158 | $0.00 | |
| 81002 | 0% | 60 | $0.00 | |
| 90670 | 0% | 111 | $0.00 | |
| Q0177 | Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 75 | $0.00 |
| 90473 | 0% | 38 | $0.00 | |
| 4025F | 0% | 64 | $0.00 | |
| 87339 | 0% | 19 | $0.00 | |
| 80305 | 0% | 29 | $0.00 | |
| 4551F | 0% | 16 | $0.00 | |
| 90648 | 0% | 40 | $0.00 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 0% | 12 | $0.00 |
| 83525 | 0% | 18 | $0.00 | |
| 99359 | Prolong nursin fac eval 15m | 0% | 18 | $0.00 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 0% | 12 | $0.00 |
| 92283 | 0% | 678 | $0.00 | |
| 96127 | 0% | 224 | $0.00 | |
| 97802 | 0% | 545 | $0.00 | |
| 96161 | 0% | 129 | $0.00 | |
| 90680 | 0% | 62 | $0.00 | |
| 87073 | 0% | 40 | $0.00 | |
| 90686 | 0% | 141 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 141 | $0.00 |
| 87084 | 0% | 64 | $0.00 | |
| J7626 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg | 0% | 64 | $0.00 |
| 1111F | 0% | 172 | $0.00 | |
| A9150 | Non-prescription drugs | 0% | 808 | $0.00 |
| 87071 | 0% | 41 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 14 | $0.00 |
| 90723 | 0% | 62 | $0.00 | |
| 83009 | 0% | 19 | $0.00 | |
| 78268 | 0% | 19 | $0.00 | |
| 99403 | 0% | 13 | $0.00 | |
| 82962 | 0% | 13 | $0.00 | |
| 87070 | 0% | 40 | $0.00 | |
| 90647 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.